The ALIVE Charity Foundation presented the sum of €120,000 as a donation to the Research, Innovation, and Development Trust (RIDT).

This contribution will be utilised to fund Cancer Research at the University of Malta, aimed at advancing the country’s understanding of cancer and improving current treatment options.

"We are proud to make this donation on World Cancer Day, a day that resonates deeply with our mission to combat this devastating disease. The funds will go towards supporting ground-breaking research projects at the University of Malta, contributing to advancements in cancer treatment and care," said Nicky Camilleri, Chairperson of the ALIVE Charity Foundation.

“The generous and regular donations by ALIVE Charity Foundation, make it possible for the University of Malta to sustain a long term vision of cutting-edge cancer research. It is very encouraging for our researchers to know that they can count on NGOs, individuals and businesses within the community, I encourage others to follow the footsteps of the ALIVE Charity Foundation,” Prof. Alfred Vella, Rector of the University of Malta, said.

Since its inception in 2013, the Foundation has donated over €820,000 for various cancer research projects. The ALIVE Charity Foundation thanked all its fund-raising partners, particularly Tum Invest, La Roche Posay, Garmin Malta, Falzon Group, Empav Engineering and Cisk 0.0, for their support, playing a pivotal role in the success of the Foundation's 2023 campaign.